CTKB(Cytek Biosciences, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $127.95M | $164.04M | $193.01M | $200.45M | $201.49M |
| 毛利润 | $79.14M | $100.97M | $109.43M | $111.11M | $104.46M |
| 营业利润 | $9.16M | −$1.80M | −$27.84M | −$20.52M | −$40.38M |
| 净利润 | $3.03M | $2.48M | −$12.15M | −$6.02M | −$66.54M |
| 经营现金流 | $4.63M | −$12.23M | $5.28M | $25.38M | −$4.69M |
| 自由现金流 | $266.00K | −$21.98M | $633.00K | $21.85M | −$8.77M |
| 摊薄每股收益 | $0.00 | $0.02 | $-0.09 | — | — |